Eventide Asset Management - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$125,091,097
+39.8%
3,958,579
+14.4%
2.25%
+48.7%
Q2 2023$89,489,530
+80.9%
3,459,201
+68.0%
1.51%
+66.7%
Q1 2023$49,462,008
+23.3%
2,059,201
+0.1%
0.91%
+14.7%
Q4 2022$40,111,500
+49.7%
2,057,000
+61.3%
0.79%
+50.1%
Q3 2022$26,788,0001,275,0000.53%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders